Advertisement
Annovis Bio Says FDA Authorizes Phase 2/3 Trial For Buntanetap In Alzheimer's Disease
(RTTNews) - Annovis Bio, Inc. (ANVS), a late-stage clinical drug platform company, announced Thursday that the U.S. Food and Drug Administration (FDA) has authorized the Phase 2/3 clinical study of buntanetap in moderate Alzheimer's Disease (AD).
Following the submission of the Phase 2a clinical safety data and the chronic toxicology data in animals, the Company requested approval to further pursue the development of buntanetap in AD.
The FDA approved the Company's development plan, study protocol and authorized the initiation of the Phase 2/3 clinical study of buntanetap in AD.
For More Such Health News, visit rttnews.com
read more
Annovis Bio Says Phase III Study Data Release For Buntanetap In Parkinson's Disease Postponed
Drug platform company Annovis Bio, Inc. (ANVS) announced Wednesday a postponement in the Phase III study data release for buntanetap in Parkinson's Disease. This adjustment is due to ongoing data cleaning efforts to ensure the accuracy and reliability of the study results.
RTTNews
|
hace 569
New York Manufacturing Index Unexpectedly Increases In August
The Federal Reserve Bank of New York released a report on Friday showing regional manufacturing activity unexpectedly grew at a faster rate in the month of August.
RTTNews
|
hace 14 minutos
U.S. Import Prices Rise More Than Expected In July
The Labor Department released a report on Friday showing import prices in the U.S. increased by more than expected in the month of July.
RTTNews
|
hace 18 minutos
U.S. Retail Sales Climb In Line With Estimates In July
A report released by the Commerce Department on Friday showed retail sales in the U.S. increased in line with economist estimates in the month of July.
RTTNews
|
hace 23 minutos
Bay Street Likely To Open Flat
Canadian shares may open somewhat flat on Friday, and the focus is on the upcoming meeting between U.S. President Donald Trump and Russian President Vladimir Putin, set to take place in Alaska later in the day.
RTTNews
|
hace 47 minutos
Taiwan Raises Growth Outlook
Taiwan's economy is expected to grow more than previously estimated this year on robust foreign demand for artificial intelligence and emerging technology applications. The economy is projected to expand 4.45 percent this year, which was revised up from 3.1 percent estimated earlier, the Directorate General of Budget, Accounting & Statistics said Friday.
RTTNews
|
hace 53 minutos
FTSE 100 Up Marginally; Miners Move Higher
U.K. stocks are gaining for a fifth straight session, with mining and energy stocks faring well on Friday. Hopes that the economic impact of Trump administration's tariff moves will not any significantly hurt British economic growth.
Expectations that the Trump - Putin summit later in the day will help end the war in Ukraine also contribute to the slightly positive mood in the market.
RTTNews
|
hace 1h 51min
Yen Rises As Japan Economy Expands In Q2
The Japanese yen strengthened against other major currencies in the Asian session on Friday, after Japan's gross domestic product expanded on quarter in the second quarter of 2025.
RTTNews
|
hace 2h 1min
